Product Information
ISOTRETINOIN 30 MG CAPSULE is a generic product labeled by Mayne Pharma, priced at $2.1254 per EA under NDC 68308078330. Its NADAC has been published 139 times since Feb 7, 2024.
FDA first approved this application on Jan 19, 2012. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Mayne PharmaNDC
68308078330
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ISOTRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA076485FDA Approved
1/19/2012
TE Code
AB1
On Market Since
5/1/2012
Pharmacological Classes
Price Statistics
The NADAC for ISOTRETINOIN 30 MG CAPSULE has been published 139 times since Feb 7, 2024, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1254 per EA |
|---|---|
| All-time high | $3.5635 (Apr 10, 2024) |
| All-time low | $1.8937 (Feb 18, 2026) |
| 52-week high | $2.3030 |
| 52-week low | $1.8937 |
| Median price | $2.2732 |
| Average price | $2.3490 |
| Largest weekly change | +44.9% (Aug 21, 2024) |
| Weeks tracked | 139 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Isotretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ISOTRETINOIN 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ISOTRETINOIN 30 MG CAPSULE, manufactured by Mayne Pharma, is $2.1254 per EA (NDC 68308078330), effective Sep 30, 2026.
How has the price of ISOTRETINOIN 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ISOTRETINOIN 30 MG CAPSULE has declined 35.5%. It has been tracked across 139 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for ISOTRETINOIN 30 MG CAPSULE?
Since Feb 7, 2024, the NADAC for ISOTRETINOIN 30 MG CAPSULE has ranged from a low of $1.8937 (Feb 18, 2026) to a high of $3.5635 (Apr 10, 2024), with a median of $2.2732 per EA.
Are there cheaper alternatives to ISOTRETINOIN 30 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ISOTRETINOIN 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ISOTRETINOIN 30 MG CAPSULE?
ISOTRETINOIN 30 MG CAPSULE (NDC 68308078330) is labeled by Mayne Pharma, and CMS classifies it as a generic product.